Concepedia

Dan Malashock

DM

Statistics

Publications

5

Citations

657

H-Index

5

Active since

2008

Affiliations

Pfizer (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Dan Malashock is an author at Pfizer (United States) specializing in medicine, bioanalysis, and biochemistry.

Top concepts

MedicineBioanalysisBiochemistryAllergyBiophysicsBiosensingBiosensorsImmunologyEngineeringPharmacology

Publications per year

2008–2022

5

Publications

5

Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet

Yasmina Abdiche, Dan Malashock, Alanna Pinkerton et al. · Analytical Biochemistry · 2008 · 395 citations

Biochemistry, Natural Sciences, Biomolecular Analysis +8

Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti‐NGF monoclonal antibody, using a repertoire of biosensors

Yasmina Abdiche, Dan Malashock, Jaume Pons · Protein Science · 2008 · 140 citations · Full text

Immunocytochemical Technique, Immunology, Neuropathic Pain +17

Exploring blocking assays using Octet, ProteOn, and Biacore biosensors

Yasmina Abdiche, Dan Malashock, Alanna Pinkerton et al. · Analytical Biochemistry · 2008 · 89 citations

Engineering, Biochemistry, Biosensing Systems +8

Biophysical and Immunological Characterization and <i>In Vivo</i> Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody Pembrolizumab

Beth Hutchins, Gary C. Starling, Mark A. McCoy et al. · Molecular Cancer Therapeutics · 2020 · 17 citations

Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy

Lars Guelen, Thierry Fischmann, Jerelyn Wong et al. · Journal for ImmunoTherapy of Cancer · 2022 · 16 citations · Full text

1–5 of 5